Egypt, ILO launch economic empowerment program to secure sustainable jobs for youth, women    'We can't wait:' Biden to push US Congress for $1.9 trillion in COVID-19 relief    De Jong leads Barcelona to win over Elche in Spanish league    2 in 5 Americans live where COVID-19 strains hospital ICUs    Ora Developers Egypt signs EGP 2.54 billion loan agreement    Defense chief orders review of military sex assault programs    Nigeria's number one lender, Access Bank, is looking at Egypt    British supermodel Naomi Campbell visits Egypt    Personal loans dominate 77.5 % of NBE's retail banking portfolio    Egyptian pop music producer Mido Mounib dies at 41    Egypt will inoculate medical staff with COVID-19 vaccination this week    Egypt's Sisi ratifies extension of state of emergency for three months    New daily Coronavirus cases continued to fall over the weekend    South African mourns death of jazz 'giant' Jonas Gwangwa    Klopp says Burnley shock can spark Liverpool turnaround    Manchester City's Guardiola says Foden must not look to emulate De Bruyne    Eight cabinet ministers to deliver statements before Egypt's parliament this week    China rescues nine miners after 14 days trapped underground: CCTV    3,000 arrested at protests demanding Navalny's release    Sudan reiterates concerns over planned 2nd GERD filling without binding deal    IMF urges deficit control in Tunisia even as protesters demand jobs    Egypt's Sisi to inaugurate fish farming project in Port Said Saturday    Egypt reports 748 new coronavirus cases, 52 deaths on Friday    Donald Trump says goodbye to the White House    BREAKING: Egypt resumes diplomatic relations with Qatar ending 4-year boycott    Egypt reports 899 new coronavirus cases, 58 deaths on Tuesday    Egypt sends medical supplies to help Jordan battle coronavirus    Egypt eyes gradual return for tourism after revenues fall to $4 bln in 2020    Seasoned Egyptian screenwriter Wahid Hamed dies at 76    Coronavirus strikes Egypt's youth team as 17 players, coach test positive    Nassef Sawiris plans to up his stake in owner of New York Knicks, Rangers    Cairo International Book Fair suspended for five months over coronavirus concerns    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    

Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.

Savills: Boom in global vaccine investment to benefit real estate investors in Middle East
Published in Amwal Al Ghad on 28 - 11 - 2020

As part of its Impacts programme, Savills, the leading global real estate advisors, has recently published some new research confirming the extent of estimated future global demand in laboratory and office space associated with life science.
The research shows the extent to which venture capital (VC) funding into such companies boomed to $2.3 billion by the end of August, comprising 1.2 percent of all global VC investment, up from an annual average of just 0.6 percent over the past five years.
To further discuss the research, Savills hosted a webinar to highlight the most recent increase in demand from life sciences companies across the Middle East region. The panel titled ‘Life Sciences – A Real Estate Bubble or Boom in the Middle East?' looked at the investors' interest in diversifying their portfolios to capture the expected increase in demand from life science companies.
In order to understand the recent growth in this trend, Savills invited to the panel regional real estate and life science experts, including Paula Walshe,Head of International Corporate Services at Savills; Marwan Abdulaziz, Managing Director at Dubai Science Park; Cenk Bildir, Senior Principle Project Manager at Medtronic; and Graham MacGregor, Project Management Associate at Savills.
The session was moderated bySteven Lang,Director Research at Savills who discussed with the panellists the key factors and trends on real estate emerging from global markets and driven by the global pandemic.
Based on Savills data and analysis, Steven Lang explained the significant level of Research & Development (R&D) investment into the global pharmaceutical and biotechnology sector. Additionally, the increased level of interest from investors includes a realisation and a need to understand how occupiers and corporates should operate in the "new normal", in terms of location and fit-out.
Commenting on life science capital raising in the Middle East, Lang said: "The period between 2015 and 2019 saw a significant increase in the annual average level of investment for vaccines companies compared to the preceding five-year period in most countries, but unsurprisingly this has now been surpassed by the eight-month total for 2020 given the scale of the pandemic emergency.
"Faster growth in the smaller vaccine-associated companies, which tend to be the main recipients of VC funding, bodes well for developing a strong life science ecosystem, which attracts the global larger corporates, and is good for real estate demand across both the offices and specialist laboratory space sectors."
Paula Walshe, Head of International Corporate Services at Savills said: "It is far too early to state the impact on demand is specifically due to the COVID-19 pandemic. However, there has been a noted increase in interest from the life sciences sector generally over the last 12 to 18 months from new companies looking to enter the market and existing companies who plan to expand their operations.
"The United States and Europe are the two main locations where we see most of our life sciences clients headquartered. From our understanding, these companies see this region as a central location for access to India and Asia pacific markets as well as a progressive and business friendly environment."
Marwan Abdulaziz, Managing Director at Dubai Science Park, said: "The talent is the core of innovation any sector needs. One of the intriguing numbers that I stumbled upon recently was the number of scientists per million in the Middle East compared to countries like Finland and the U.S. Finland for example, has 7,000 scientists per one million while the U.S. has 5,000 scientists per one million. However, the entire Middle East has only one thousand scientists per one million.
"We are unfortunately very far off from countries that are developing and coming up with innovations in different areas such as vaccines, pharmaceuticals, and biotech. There needs to be a lot of effort done in the aspect of nurturing that talent, and we have seen great examples in such as the New York University in Abu Dhabi. This would probably change in the coming 5-10 years, but talent is one of the key aspects we need to grow and nurture in the Middle East."
Global Trend
Savills analysed VC funding raised by vaccine companies by country and by the annual average of money going into vaccine companies headquartered by country, over three time periods, including in the past eight months. The UK and Switzerland saw extremely strong growth between 2015 and 2019 compared to the preceding five-year period. For the UK, this growth was 106 percent and for Switzerland it was 39 percent, putting them in a robust position for their vaccine-related sectors to continue to expand, says Savills. Since the outbreak of Covid-19 the UK has seen a significant acceleration in activity related to vaccine development with a brand-new Vaccines Manufacturing Innovation Centre in Harwell, Oxford, being expedited to complete by Q4 2021.
According to Savills, the U.S. and Germany have been largest recipients of VC investment into vaccine companies this year, while others such as Canada and France have witnessed significant growth in 2020 compared to the preceding five-year period.

Clic here to read the story from its source.